Project Grant 2537879
- Federal Grant Award Summary Ivsonance Biomedical Inc. received a $305,000 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) effective October 1, 2025, through September 30, 2026. The awardee, based in Ithaca, New York, is developing a semi-automated acoustic tweezer system that uses modulated sound waves to provide contactless micromanipulation of delicate biological materials...
- Federal Grant Award Summary Primary Bioscience, Inc. received a $305,000 Small Business Technology Transfer (STTR) Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084) effective July 15, 2025, with a completion date of June 30, 2026. The company is developing an ultra-sensitive biosensor capable of single-molecule protein analysis and sequencing. The technology integrates a nanopatterned chip with a proprietary amino acid and...
- Federal Project Grant Award Summary The National Science Foundation's Directorate for Technology, Innovation, and Partnerships (TIP) awarded $305,000 to a small business under the SBIR Phase I program (CFDA 47.084) to develop a novel gene therapy platform that overcomes the cargo size limitations of adeno-associated virus (AAV) delivery systems. The project, initiated July 1, 2026 with completion targeted for December 31, 2027, focuses on designing and validating a scalable platform to deliver...
- Federal Grant Award Summary Sound Innovation LLC received a $527,498 Project Grant award dated August 15, 2025, from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The company is developing SOUNDSCAPE, a portable small animal imaging device designed to accelerate preclinical drug development by providing a cost-effective alternative to existing imaging...
- Federal Project Grant Summary Phase, Inc. received a $304,761 National Science Foundation (NSF) Small Business Technology Transfer (STTR) Phase I award under the Technology, Innovation, and Partnerships program (CFDA 47.084) effective June 1, 2026, through May 31, 2027. The project advances high-resolution 3D printing technology for polydimethylsiloxane (PDMS) microfluidic devices—commonly referred to as "labs on a chip"—which are essential tools for disease research, drug testing, and...
- Federal Grant Award Summary This $300,000 EAGER (Early-Concept Grant for Exploratory Research) award from the National Science Foundation's Division of Civil, Mechanical, and Manufacturing Innovation (CFDA 47.041—Engineering) supports fundamental research at Texas Tech University to develop innovative acoustic array-assisted three-dimensional (3D) bioprinting technology. The project, active from September 1, 2025, through August 31, 2027, focuses on enabling dynamic, layer-by-layer cell...
- Federal Project Grant Award Summary Spectral Therapeutics, Inc. received a $304,950 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation's Directorate for Technology, Innovation, and Partnerships (CFDA 47.084) on July 1, 2026, with completion anticipated by March 31, 2027. The company is developing a novel, ultra-miniaturized drug discovery platform that integrates III-V semiconductor laser particles as spectral barcodes into polymer beads for...
- Federal Grant Award Summary Heliowave Technologies Inc. received a $175,000 Project Grant from the U.S. Department of Agriculture National Institute of Food and Agriculture (USDA NIFA) under the Small Business Innovation Research (SBIR) Program (CFDA 10.212), awarded September 1, 2025, with completion targeted April 30, 2027. The award funds development of HELIOCLEAN, a portable, palm-sized biosensing device designed to achieve rapid, sensitive, and accurate detection of foodborne pathogens...
- Federal Grant Award Summary Biostorex LLC received a $303,998 Small Business Technology Transfer (STTR) Phase I Project Grant from the National Science Foundation (NSF) Directorate for Technology, Innovation, and Partnerships (CFDA 47.084), awarded January 1, 2027, with completion anticipated by December 31, 2027. The project focuses on developing novel enzymatic DNA-synthesis technology for scalable and sustainable long-term digital data storage. The research aims to engineer a light-responsive...
- Federal Grant Award Summary Avant Genomics, Inc. received a $305,000 Small Business Innovation Research (SBIR) Phase I project grant from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), awarded October 1, 2025, with a completion date of September 30, 2026. The company is developing an automated microfluidic-based system that streamlines bisulfite conversion, a critical and time-consuming step in preparing circulating tumor DNA...
Helix Acoustics, Inc. received a $304,948 Small Business Technology Transfer (STTR) Phase I award from the National Science Foundation's Directorate for Technology, Innovation, and Partnerships (CFDA 47.084) on July 1, 2026, for research and development activities in Roanoke, Virginia. The project focuses on developing a benchtop focused ultrasound transducer array system designed to accelerate DNA extraction from complex biological samples. The core innovation replaces conventional multi-step chemical-based sample preparation workflows with precisely controlled acoustic cavitation technology that simultaneously homogenizes tissue and lyses cells, enabling rapid processing of challenging sample types including plant materials, dense tissues, and complex bacterial cultures. The resulting DNA extraction platform aims to address critical bottlenecks in genetic testing workflows across diagnostics, agriculture, food safety, and forensics sectors by reducing processing time, improving DNA quality, and increasing throughput. By simplifying and accelerating sample preparation—a labor-intensive universal requirement in genetic testing—the technology is intended to improve diagnostic accuracy, enable new applications of genetic testing, and strengthen biosecurity and defense capabilities. The project is scheduled for completion by June 30, 2027.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $304.9k | 6/17/26 |